These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21767531)

  • 1. In-vitro recording of adult zebrafish heart electrocardiogram - a platform for pharmacological testing.
    Tsai CT; Wu CK; Chiang FT; Tseng CD; Lee JK; Yu CC; Wang YC; Lai LP; Lin JL; Hwang JJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1963-7. PubMed ID: 21767531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated perfused and paced guinea pig heart to test for drug-induced changes of the QT interval.
    Cheng HC; Incardona J; McCullough B
    J Pharmacol Toxicol Methods; 2006; 54(3):278-87. PubMed ID: 16507347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
    Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
    Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration.
    Lengyel C; Iost N; Virág L; Varró A; Lathrop DA; Papp JG
    Br J Pharmacol; 2001 Jan; 132(1):101-10. PubMed ID: 11156566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple-to-use, reference criteria for revealing drug-induced QT interval prolongation in conscious dogs.
    Schmitt MW; Von Landenberg F; Poth H; Wimmer E; Goddemeier T; Cavero I
    Eur J Pharmacol; 2007 Jan; 554(1):46-52. PubMed ID: 17112506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoproterenol exacerbates a long QT phenotype in Kcnq1-deficient neonatal mice: possible roles for human-like Kcnq1 isoform 1 and slow delayed rectifier K+ current.
    Knollmann BC; Casimiro MC; Katchman AN; Sirenko SG; Schober T; Rong Q; Pfeifer K; Ebert SN
    J Pharmacol Exp Ther; 2004 Jul; 310(1):311-8. PubMed ID: 15004216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
    J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater quinidine-induced QTc interval prolongation in women.
    Benton RE; Sale M; Flockhart DA; Woosley RL
    Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT prolongation modifies dynamic restitution and hysteresis of the beat-to-beat QT-TQ interval relationship during normal sinus rhythm under varying states of repolarization.
    Fossa AA; Wisialowski T; Crimin K
    J Pharmacol Exp Ther; 2006 Feb; 316(2):498-506. PubMed ID: 16204470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
    Takahara A; Sugiyama A; Hashimoto K
    Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model.
    Yang Z; Shi G; Li C; Wang H; Liu K; Liu Y
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):815-20. PubMed ID: 15250869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
    Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting drug-induced prolongation of the QRS complex: new insights for cardiac safety assessment.
    Cros C; Skinner M; Moors J; Lainee P; Valentin JP
    Toxicol Appl Pharmacol; 2012 Dec; 265(2):200-8. PubMed ID: 23073507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.
    Molnar J; Zhang F; Weiss J; Ehlert FA; Rosenthal JE
    J Am Coll Cardiol; 1996 Jan; 27(1):76-83. PubMed ID: 8522713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
    Hansen RS; Olesen SP; Rønn LC; Grunnet M
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Screening of Kv7.1 and Kv7.1/KCNE1 Activators as Potential Antiarrhythmic Drugs in the Zebrafish Heart.
    De la Cruz A; Wu X; Rainer QC; Hiniesto-Iñigo I; Perez ME; Edler I; Liin SI; Larsson HP
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.